
    
      The purpose of this clinical Study is Tisporin Eye Drops 0.05%(Cyclosporine ophthalmic
      solution) group and Restasis Eye Drops 0.05%(Cyclosporine ophthalmic suspension) group 12
      weeks after treatment, each treatment group comparisons for evaluation of efficacy and safety
      in Moderate to Severe Dry Eye Disease.

      - Corneal staining test, Ocular surface disease index (OSDI), Tear break up time (TBUT),
      Non-anesthetic Schirmer test
    
  